1 MIECHV On-Site Compliance Review Awardee Feedback Form_M

Voluntary Partner Surveys to Implement Executive Order 12862 in the Health Resources and Services Administration

FORM MIECHV On-Site Compliance Review Awardee Feedback Form_May2021

OMB: 0915-0212

Document [docx]
Download: docx | pdf

OMB Control No. 0915-0212

Expiration Date: 04/30/2024


Maternal, Infant, and Early Childhood

Home Visiting (MIECHV) Program On-site Compliance Review

Awardee Feedback Form

OMB Control No. 0915-0212

Expiration Date: 4/30/2024

Public Burden Statement: The purpose of this information collection request is to assess awardees satisfaction with the site visit process which is being supported through a contracted TA provider. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this project is 0915-0212. Public reporting burden for this collection of information is estimated to average .25 hours per response, including the time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 14N136B, Rockville, Maryland, 20857.

Introduction Letter


* 1. Dear Awardee,


Thank you for participating in the recent HRSA MIECHV Compliance Review site visit. In an effort to continuously improve our processes we would like to get your feedback on the site visit and the staff assigned to the site visit. This survey will allow us to gather feedback and report any successes, recommendations for improvement, and/or challenges to HRSA immediately.


Your feedback helps us review our processes, assess our staff, and make any necessary improvements. Your responses are anonymous and the survey should take less than 10 minutes to complete. Please complete it within 5 business days of the date of receipt. If you have questions about the survey please contact the Project Manager, [name, email, phone number]. We look forward to your feedback.

Shape2 Shape1

The dropdown box above will list the current HRSA project officer’s names.



Pre-Site Visit


This section is an evaluation of the pre-site visit activities that occurred in preparation for your site visit. When answering these questions please think specifically about the planning phase of the site visit.

* 2. Did you participate in a pre-site visit conference call?

Yes No


  • 3. The planning for the site visit was timely and responsive to our needs.

Shape4

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 4. The Site Visit Assessment Tool helped us prepare for the site visit.

Shape5

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 5. The pre-site visit planning call helped us prepare for the site visit.

Shape6

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 6. The virtual site visit readiness checklist helped us prepare for the site visit.

Shape7

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


Shape8
  • 7. Expectations of the site visit were clearly articulated.

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 8. Please provide any additional comments/ recommendations about the pre-site visit process.

Shape9



Site Visit – Programmatic Consultant


This section is an evaluation of the programmatic consultant assigned to your site visit. When answering these questions please think specifically about that member of the site visit team.

  • 9. Site Visit Staff:

    Shape10
  • Who is the Programmatic Consultant that visited you?


The Programmatic Consultant…

  • 10. Exhibited appropriate knowledge of MIECHV programs.

Shape11

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 11. Was well prepared, demonstrated knowledge of our organization, the Site Visit Assessment Tool and the HRSA site visit process.

Shape12

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 12. Was objective and professional

Shape13

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A



  • 13. Effectively utilized the Site Visit Assessment Tool and the sample questions to frame the discussion and to add clarity to the items being assessed.

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A

Shape14



  • 14. The site visit debriefing provided an accurate account of the discussions during the site visit.

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A

Shape15


15. Please provide any additional comments concerning the programmatic consultant.












Shape16

Site Visit - Fiscal Consultant



This section is an evaluation of the fiscal consultant assigned to your site visit. When answering these questions please think specifically about that member of the site visit team.

  • 16. Site Visit Staff:

Shape17
  • Who is the Fiscal Consultant that visited you?


The Fiscal Consultant…

  • 17. Exhibited appropriate knowledge of MIECHV programs

Shape18

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 18. Was well prepared, demonstrated knowledge of our organization, the Site Visit Assessment Tool and the HRSA site visit process.

Shape19

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 19. Was objective and professional.

Shape20

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A



  • 20. Effectively utilized the Site Visit Assessment Tool and the sample questions to frame the discussion and to add clarity to the items being assessed.

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A

Shape21


  • 21. The site visit debriefing provided an accurate account of the discussions during the site visit.

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A

Shape22


  • 22. Please provide any additional comments concerning the fiscal consultant.


Shape23






Site Visit - Notetaker

Shape24


This section is an evaluation of the notetaker assigned to your site visit. When answering these questions please think specifically about that member of the site visit team.


  • 23. The note taker demonstrated professionalism in supporting the site visit.

Shape25

Disagree Strongly Disagree Undecided Agree Strongly Agree N/A


  • 24. Please provide any additional comments concerning the notetaker.

Shape26




Virtual Site Visit

Shape27

This section is an evaluation of the site visit activities that were conducted virtually. When answering these questions please think specifically about the virtual site visit not the in-person site visit.


  • 25. What were the most significant challenges you encountered during the planning phase of the virtual site visit? Check all that apply.

    • Document Availability

    • Technology (Please describe: ______________)

    • Staff or Partners Not Available

    • Limited Time for Discussions with Consultants and HRSA Staff

    • Virtual Meeting Days Too Long

    • Virtual Meeting Days Too Short

    • Other (Please describe: ______________)

    • No Challenges







Virtual Site Visit



Shape28


  • 26. What were the most significant challenges you encountered during the virtual site visit review? Check all that apply.


    • Document Availability

    • Technology (Please describe: ______________)

    • Staff or Partners Not Available

    • Limited Time for Discussions with Consultants and HRSA Staff

    • Virtual Meeting Days Too Long

    • Virtual Meeting Days Too Short

    • Other (Please describe: ______________)

    • No Challenges


  • 27. Please provide any additional comments about the virtual site visit process.







Thank you for completing this survey! If you have additional comments or questions about this survey please contact the Project Manager, [name, email, phone number].


Shape3

1


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created0000-00-00

© 2024 OMB.report | Privacy Policy